Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

SEVA PAIN AND WELLNESS

NPI: 1043835309 · TULSA, OK 74104 · Pain Medicine (Anesthesiology) Physician · NPI assigned 06/12/2020

$949K
Total Medicaid Paid
38,821
Total Claims
37,096
Beneficiaries
19
Codes Billed
2020-10
First Month
2024-11
Last Month

Provider Details

Authorized OfficialPATEL, JAYEN (MEMBER)
Parent OrganizationSEVA PAIN AND WELLNESS
NPI Enumeration Date06/12/2020

Related Entities

Other providers sharing the same authorized official: PATEL, JAYEN

ProviderCityStateTotal Paid
OKLAHOMA PAIN AND WELLNESS CENTER, PLC TULSA OK $1.14M
TULSA AMBULATORY PROCEDURE CENTER LLC TULSA OK $199K
SEVA ANESTHESIA SERVICES OK PLC TULSA OK $8K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2020 1,352 $12K
2021 7,960 $178K
2022 14,561 $341K
2023 9,975 $263K
2024 4,973 $156K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 20,927 19,847 $825K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 868 845 $35K
80305 2,843 2,744 $31K
96127 10,513 10,076 $19K
99484 2,201 2,180 $14K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 81 81 $8K
64635 139 133 $6K
64493 148 142 $3K
99152 511 483 $2K
64636 113 107 $2K
64494 109 104 $1K
64483 28 28 $1K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 14 13 $682.36
27096 14 14 $433.04
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) 214 203 $302.96
20610 14 14 $163.02
36416 43 42 $109.74
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 27 27 $48.50
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 14 13 $31.76